Stock Market Nation desk

Food & Health

Food, healthcare, biotechnology, wellness, and consumer health markets.

11 stories

Analysis

Pipeline Pressures Challenge Novartis Post Avidity Deal

Novartis's Avidity acquisition faces scrutiny after neuromuscular drug trial misses key goals. Explore the implications on deal valuation.

Food & Health

FDA approval of Zanvastro may impact rare disease market valuation. Explore deal terms and sector implications for Ionis.

Sep 44 min read

Food & Health

Sep 33 min read

Food & Health

Sep 24 min read

Food & Health

Sep 13 min read

Food & Health

Sep 13 min read

Food & Health

J&J's Imaavy gets FDA nod for wAIHA, reshaping deal terms and revenue paths in rare-disease pharma.

Aug 253 min read

Food & Health

RGX-121 trial halt impacts Regenxbio's valuation, highlighting sector risks with spinal nodules discovery.

Aug 243 min read

Food & Health

Patent ruling forces costly royalties on Guardant, affecting its market growth and revenue projections significantly.

Aug 243 min read

Food & Health

Regeneron climbs 4% with Pasatru's FDA nod, enhancing its foothold in orphan-drug market with premium pricing potential.

Aug 203 min read

Food & Health

Explore JBS's offer for remaining Pilgrim's Pride shares, focusing on deal terms and valuation impact on investors.

Aug 193 min read